Literature DB >> 16183030

Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.

Valdemar Máximo1, Jorge Lima, Paula Soares, Tiago Botelho, Lígia Gomes, Manuel Sobrinho-Simões.   

Abstract

Despite the numerous studies describing a high frequency of mitochondrial DNA (mtDNA) somatic mutations in many types of human primary tumors the mechanisms that generate such mutations and the role of mtDNA mutations in tumor development remain unclear. We present the results obtained in the study of mtDNA displacement-loop (D-Loop) region in a series of 66 thyroid tumors, and respective adjacent parenchyma, including benign (adenomas, n=30) and malignant tumors (follicular carcinomas, n=17 and papillary carcinomas, n=19). Three repetitive regions were analyzed [two mononucleotide repetitive (D310 and D568) and one dinucleotide repetitive (D514)]. Thirty-two (48.5%) of the 66 tumors [15/30 (50.0%) adenomas, 8/17 (47.1%) follicular carcinomas and 9/19 (47.4%) papillary carcinomas] harbored somatic insertions in D-Loop repetitive regions. Twenty (30.3%) of the 66 tumors [12/30 (40%) adenomas, 3/17 (17.6%) follicular carcinomas and 5/19 (26.3%) papillary carcinomas] harbored somatic insertions at the D310 mononucleotide repeat. Three (4.6%) of the 66 tumors [1/30 (3.3%) adenomas and 2/17 (11.8%) follicular carcinomas] harbored somatic insertions at the D568 mononucleotide repeat. Fifteen (22.7%) of the 66 tumors [3/30 (10.0%) adenomas, 5/17 (29.4%) follicular carcinomas and 7/19 (36.8%) papillary carcinomas] harbored somatic insertions at the D514 dinucleotide repeat. Five (7.6%) of the 66 tumors [1/30 (3.3%) adenomas, 1/17 (5.9%) follicular carcinomas and 2/19 (10.5%) papillary carcinomas] harbored somatic insertions in more than one region, and in one of them (a carcinoma) alterations were detected in the three regions. We conclude that mutations in the mtDNA D-Loop region are frequent in benign and malignant thyroid tumors and cannot be considered a marker of malignancy. Our study shows, furthermore, two repetitive regions (D310 and D514) that appear to be susceptible to mutation in thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183030     DOI: 10.1016/j.mito.2005.06.003

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  5 in total

Review 1.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

Review 2.  Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair.

Authors:  Timothy L Scott; Suganya Rangaswamy; Christina A Wicker; Tadahide Izumi
Journal:  Antioxid Redox Signal       Date:  2013-10-15       Impact factor: 8.401

3.  Genomic and immunohistochemical characterisation of a lacrimal gland oncocytoma and review of literature.

Authors:  Lauge Hjorth Mikkelsen; Simon Andreasen; Linea Cecilie Melchior; Marta Persson; Jeppe Dyrberg Andersen; Vania Pereira; Peter Bjerre Toft; Niels Morling; Göran Stenman; Steffen Heegaard
Journal:  Oncol Lett       Date:  2017-08-03       Impact factor: 2.967

4.  Altered levels of circulating nuclear and mitochondrial DNA in patients with Papillary Thyroid Cancer.

Authors:  Ewelina Perdas; Robert Stawski; Krzysztof Kaczka; Dariusz Nowak; Maria Zubrzycka
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

Review 5.  Research highlights on contributions of mitochondrial DNA microsatellite instability in solid cancers - an overview.

Authors:  Abdul Aziz Mohamed Yusoff; Siti Muslihah Abd Radzak; Siti Zulaikha Nashwa Mohd Khair
Journal:  Contemp Oncol (Pozn)       Date:  2022-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.